G2-S16 proves to be safe and effective topical vaginal microbicide against HIV in vivo Oct. 31, 2018 No Comments
Positive long-term data presented from pivotal phase III AMBER study of Symtuza Oct. 31, 2018 No Comments
Inovio presents updated results from HVTN 098 phase I clinical study of PENNVAX-GP Oct. 26, 2018 No Comments
Merck Sharp & Dohme enrolling patients in phase I study of MK-8583 for HIV-1 Oct. 22, 2018 No Comments
MacroGenics studies MGD-014 in patients with HIV infection on suppressive ART Oct. 22, 2018 No Comments
Aelix and Gilead collaborate to study HTI T-cell vaccine with vesatolimod in HIV Oct. 19, 2018 No Comments
RSS